Laboratory survey of drug-resistant Streptococcus pneumoniae in New York City, 1993-1995

Emerging Infectious Diseases

Volumn 4, Issue 1, 1998, Pages 113-116

  Heffernan, Richard ^a   Henning, Kelly ^a   Labowitz, Anne ^a   Hjelte, Annette ^a   Layton, Marcelle ^a  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; OXACILLIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATION; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HOSPITAL LABORATORY; LABORATORY DIAGNOSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRACTICE GUIDELINE; PREVALENCE; REVIEW; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 0031848456     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0401.980116     Document Type: Review

References (10)

1. Hoffman J, Cetron MS, Farley MM, Baugham WS, Facklam RR, Elliott JA, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995;333:481-6.
2. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994;271:1831-5.
3. Doern GV, Brueggemann A, Holley HP, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996;40:1208-13.
4. Butler JC, Hoffmann J, Cetron MS, Elliott JA, Facklam RR, Breiman RF, et al. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's pneumococcal sentinel surveillance system. J Infect Dis 1996:174:986-93.
5. Cetron MS, Jernigan DB, Breiman RF, The DRSP Working Group. Action plan for drug-resistant Streptococcus pneumoniae. Emerg Infect Dis 1995;1:64-5.
6. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. M7-A4. Villanova (PA): The Committee; 1997.
7. Arnold KE, Leggiadro RJ, Breiman RF, Lipman HB, Schwartz B, Appleton MA, et al. Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J Pediatr 1996;128:757-64.
8. Appelbaum PC. Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae. Pediatr Infect Dis J 1996;15:932-9.
9. Chesney PJ, Wilimas JA, Presbury G, Abbasi S, Leggiadro RJ, Davis Y, et al. Penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae causing sepsis and meningitis in children with sickle cell disease. J Pediatr 1995;127:526-32.
10. Munford RS, Murphy TB. Antimicrobial resistance in Streptococcus pneumoniae: can immunization prevent its spread? J Investig Med 1994;42:613-21.